Intervention

Undergo EBRT

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 1 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials1

Recruiting1

Common conditions12

Lead sponsors shown1

Clinical trials

1 shown

Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic TherapyNCT02945579 · 2017-01-20

RECRUITING

Common conditions

Estrogen Receptor Negative1 HER2 Positive Breast Carcinoma1 HER2/Neu Negative1 Invasive Breast Carcinoma1 Progesterone Receptor Negative1 Stage I Breast Cancer AJCC v71 Stage IA Breast Cancer AJCC v71 Stage IB Breast Cancer AJCC v71 Stage II Breast Cancer AJCC v6 and v71 Stage IIA Breast Cancer AJCC v6 and v71 Stage IIB Breast Cancer AJCC v6 and v71 Triple-Negative Breast Carcinoma1

Leading sponsors

M.D. Anderson Cancer Center 1

Trial status mix

RECRUITING1

Phase mix

NA1

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.